BioInfra

BioInfra is a contract research organization (CRO), a company that runs clinical and laboratory tests on behalf of pharmaceutical firms rather than developing its own drugs.

It provides services including bioequivalence testing for generic medicines, early-phase clinical trials for improved drugs, full regulatory clinical trials across all phases, immunoassay analysis for large-molecule biologics, and finished-drug quality testing. Listed on KOSDAQ, Korea's tech and small-cap board, it operates across four specialized divisions, each focused on a distinct stage of the drug-development and quality-assurance process.